Publication:
Comparative Efficacy of First-Line Natalizumab Versus IFNb or Glatiramer Acetate in Relapsing MS

dc.authorwosidIuliano, Gerardo(/I-1152-2012
dc.authorwosidKubala Havrdova, Eva/P-4892-2017
dc.authorwosidHavrdova, Eva/P-4892-2017
dc.authorwosidHorakova, Dana/O-3598-2017
dc.authorwosidKappos, Ludwig/Acq-4894-2022
dc.authorwosidLugaresi, Alessandra/C-7743-2012
dc.authorwosidHoráková, Dana/O-3598-2017
dc.contributor.authorSpelman, T.
dc.contributor.authorKalincik, T.
dc.contributor.authorJokubaitis, V.
dc.contributor.authorZhang, A.
dc.contributor.authorPellegrini, F.
dc.contributor.authorWiendl, H.
dc.contributor.authorButzkueven, H.
dc.contributor.authorIDKubala Havrdova, Eva/0000-0002-9543-4359
dc.contributor.authorIDHoráková, Dana/0000-0003-1915-0036
dc.date.accessioned2025-12-11T01:17:54Z
dc.date.issued2015
dc.departmentOndokuz Mayıs Üniversitesien_US
dc.department-temp[Spelman, T.; Kalincik, T.; Jokubaitis, V.; Butzkueven, H.] Royal Melbourne Hosp, Dept Neurol, Parkville, Vic 3050, Australia; [Zhang, A.; Pellegrini, F.; Belachew, S.; Hyde, R.] Biogen Idec Inc, Cambridge, MA USA; [Wiendl, H.] Univ Munster, Dept Neurol, D-48149 Munster, Germany; [Verheul, F.] Groene Hart Ziekenhuis, Gouda, Netherlands; [Lugaresi, A.] Univ G DAnnunzio, MS Ctr, Dept Neurosci Imaging & Clin Sci, Chieti, Italy; [Havrdova, E.; Horakova, D.] Charles Univ Prague, Prague, Czech Republic; [Grammond, P.] Ctr Readaptat Deficience Phys Chaudiere Appalache, Levis, PQ, Canada; [Duquette, P.; Prat, A.] Hop Notre Dame De Bon Secours, Montreal, PQ, Canada; [Iuliano, G.] Osped Riuniti Salerno, Salerno, Italy; [Terzi, M.] 19 Mayis Univ, Samsun, Turkey; [Izquierdo, G.] Hosp Univ Virgen Macarena, Seville, Spain; [Hupperts, R.] Orbis Med Ctr, Sittard Geleen, Netherlands; [Boz, C.] Farabi Hosp, KTU Med Fac, Trabzon, Turkey; [Pucci, E.; Giuliani, G.] ASUR Marche AV3, Neurol Unit, Macerata, Italy; [Sola, P.] Nuovo Osped Civile S Agostino Estense, Modena, Italy; [La Spitaleri, D.] AORN San Giuseppe Moscati, Avellino, Italy; [Lechner-Scott, J.] John Hunter Hosp, Newcastle, NSW, Australia; [Bergamaschi, R.] Neurol Inst IRCCS Mondino, Pavia, Italy; [Grand'Maison, F.] Hop Charles LeMoyne, Neuro Rive Sud, Montreal, PQ, Canada; [Granella, F.] Hop Charles LeMoyne, Neuro Rive Sud, Parma, Italy; [Kappos, L.] Univ Basel Hosp, Dept Neurol, CH-4031 Basel, Switzerland; [Trojano, M.] Univ Bari, Dept Basic Med Sci Neurosci & Sense Organs, Bari, Italyen_US
dc.descriptionKubala Havrdova, Eva/0000-0002-9543-4359; Horáková, Dana/0000-0003-1915-0036en_US
dc.description.woscitationindexScience Citation Index Expanded - Conference Proceedings Citation Index - Science
dc.identifier.endpage259en_US
dc.identifier.issn1352-4585
dc.identifier.issn1477-0970
dc.identifier.scopusqualityQ1
dc.identifier.startpage258en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12712/42655
dc.identifier.volume21en_US
dc.identifier.wosWOS:000365729400450
dc.identifier.wosqualityQ1
dc.language.isoenen_US
dc.publisherSage Publications Ltden_US
dc.relation.ispartofMultiple Sclerosis Journalen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleComparative Efficacy of First-Line Natalizumab Versus IFNb or Glatiramer Acetate in Relapsing MSen_US
dc.typeConference Objecten_US
dspace.entity.typePublication

Files